Lavipharm S.A. (ATH:LAVI)

Lavipharm Revenue

Lavipharm had revenue of 13.35 million EUR in the quarter ending June 30, 2025, with 12.92% growth. This brings the company's revenue in the last twelve months to 54.66 million, up 16.44% year-over-year. In the year 2024, Lavipharm had annual revenue of 52.95 million with 10.68% growth.

• Revenue (ttm): 54.66M
• Revenue Growth: +16.44%
• P/S Ratio: 2.46
• Revenue / Employee: 193.82K
• Employees: 299
• Market Cap: 134.62M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	52.95M	5.11M	10.68%
Dec 31, 2023	47.84M	8.78M	22.48%
Dec 31, 2022	39.06M	-667.00K	-1.68%
Dec 31, 2021	39.72M	2.09M	5.54%
Dec 31, 2020	37.64M	4.05M	12.06%